Siegel D, Murphy C, Wangsness K, Perry A, Smith I. Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma. J of Skin [Internet]. 2022Mar.4 [cited 2024Sep.20];6(2):109-21. Available from: https://dermsquared.com/skin/article/view/1475